NEPHROS INC (NEPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 7M 14M 21M FY10: 2.9M FY11: 2.2M FY12: 1.8M FY13: 1.7M FY14: 1.7M FY15: 1.9M FY16: 2.3M FY17: 3.8M FY18: 5.7M FY19: 10.3M FY20: 8.6M FY21: 10.2M FY22: 10M FY23: 14.2M FY24: 14.2M FY25: 18.8M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 4M 8M 12M FY10: 1.1M FY11: 868K FY12: 1.1M FY13: 842K FY14: 1.2M FY15: 1.1M FY16: 1.3M FY17: 2.3M FY18: 3.2M FY19: 6.1M FY20: 4.9M FY21: 5.6M FY22: 4.7M FY23: 8.4M FY24: 8.7M FY25: 11.6M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY10: -1.9M FY11: -2.3M FY12: -3.3M FY13: -3.3M FY14: -2.7M FY15: -3.4M FY16: -2.9M FY17: -2.2M FY18: -3M FY19: -3.2M FY20: -4.3M FY21: -3.3M FY22: -4.3M FY23: -1.6M FY24: 6K FY25: 1.1M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-15M -10M -5M 0 5M 10M 15M FY09: -12.1M FY10: 3.9M FY11: -7M FY12: -6.6M FY13: 1.3M FY14: -7.4M FY15: -3.1M FY16: -3M FY17: -809K FY18: -3.4M FY19: -3.2M FY20: -4.5M FY21: -3.9M FY22: -7.1M FY23: -1.6M FY24: 74K FY25: 1.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 2.5M 5M 7.5M FY17: 1.5M FY18: 2.5M FY19: 4.2M FY20: 3.6M FY21: 4.6M FY22: 5.2M FY23: 5.8M FY24: 5.4M FY25: 7.2M FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M FY10: -1.3M FY11: -1.3M FY12: -1.5M FY13: -3.6M FY14: -2.5M FY15: -3.8M FY16: -2.1M FY17: -77K FY18: -3.7M FY19: -2.3M FY20: -6.9M FY21: -1.4M FY22: -3.2M FY23: 827K FY24: -492K FY25: 1.6M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M FY10: -1.3M FY12: -1.6M FY13: -3.6M FY15: -3.8M FY16: -2.2M FY19: -2.3M FY20: -7.1M FY21: -1.5M FY22: -3.4M FY23: 752K FY24: -547K FY10 FY12 FY13 FY15 FY16 FY19 FY20 FY21 FY22 FY23 FY24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 9M 18M 27M FY10: 2.1M FY13: 20.8M FY14: 23.8M FY21: 10M FY22: 10.3M FY23: 10.4M FY24: 10.6M FY25: 11M FY10 FY13 FY14 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.60 -0.80 0.00 0.80 1.60 2.40 Q4 '10: 1.86 Q1 '11: 1.93 Q2 '11: 2.05 Q3 '11: 2.19 Q4 '11: -0.88 Q1 '12: -0.75 Q2 '12: -0.76 Q3 '12: -0.79 Q4 '12: -0.58 Q1 '13: -0.60 Q2 '13: -0.56 Q3 '13: -0.52 Q4 '13: -0.16 Q1 '14: -0.28 Q2 '14: -0.46 Q1 '16: -0.12 Q2 '16: -0.08 Q3 '16: -0.07 Q4 '16: -0.06 Q1 '17: -0.05 Q2 '17: -0.04 Q3 '17: -0.04 Q4 '17: -0.02 Q1 '18: -0.04 Q2 '18: -0.13 Q3 '18: -0.20 Q4 '18: -0.31 Q1 '19: -0.48 Q2 '19: -0.52 Q3 '19: -0.54 Q4 '19: -0.46 Q1 '20: -0.39 Q2 '20: -0.44 Q3 '20: -0.46 Q4 '20: -0.52 Q1 '21: -0.45 Q2 '21: -0.38 Q3 '21: -0.38 Q4 '21: -0.41 Q1 '22: -0.55 Q2 '22: -0.55 Q3 '22: -0.74 Q4 '22: -0.73 Q1 '23: -0.56 Q2 '23: -0.48 Q3 '23: -0.19 Q4 '23: -0.15 Q1 '24: -0.14 Q2 '24: -0.13 Q3 '24: -0.09 Q4 '24: 0.01 Q1 '25: 0.08 Q2 '25: 0.13 Q3 '25: 0.14 Q4 '25: 0.11 Q1 '26: 0.07 Q2 '26: 0.16 Q4 '10 Q4 '12 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.